Latest ArticlesBy adding different volume fractions of ethanol into 0.1 mol/L hydrochloric acid and increasing the rotational speed, the risk of dose dumping of gliclazide(1) sustained-release tablets (self-made and reference preparations) was evaluated by HPLC, and the detection method was validated . The results showed that the release behavior of the reference preparation and the self-made tablets was basically the same after adding different volume fractions of ethanol in hydrochloric acid and increasing the rotational speed. The similarity factor(f 2) values were all greater than 50, and there was no dose dumping phenomenon. This study also found that 1 degraded very rapidly in the hydrochloric acid containing ethanol, with the degradation rate of about 40% in one hour, resulting in impurity A and impurity C. The impurity contents had far exceeded the acceptable limits specified by the quality standard. It was suggested that when taking the 1 sustained-release tablets, alcohol consumption should be prohibited in order to avoid increasing unknown safety risks due to excessive impurities.
An ICP-MS method was established to determine the contents of eleven elemental impurities, including lead(Pb), cadmium(Cd), mercury(Hg), arsenic(As), cobalt(Co), vanadium(V), nickel(Ni), lithium(Li), antimony(Sb), copper(Cu), and chromium(Cr), in paricalcitol(1). The sample was pretreated by microwave digestion method, with bismuth(Bi), germanium(Ge), and scandium(Sc) as internal standards. The kinetic energy discrimination(KED) collision mode was used, and the sample was injected into a glass concentric atomizer. The radio frequency forward power was 1 300 W, the atomization gas flow rate was 0.8 L/min, the plasma gas flow rate was 15.0 L/min, and the auxiliary gas flow rate was 1.2 L/min. The results showed that it was linear for above eleven elemental impurities in the concentration range of 25% - 200%. The quantification limits were 0.007 - 2.023 ng/mL, the average sample recoveries(n=9) were 86.0% - 104.9%, and RSDs(n=6) in the repeatability test were less than 2.3%. The established method is accurate and highly sensitive, which can be used for the trace control of eleven elemental impurities in 1.
The quality and safety of non-sterile pharmaceutical products are affected by microbial contamination, so the microbial contamination control is an important measure to ensure the safety of pharmaceuticals. Water activity is a key physicochemical parameter that affects the growth and reproduction of microorganisms, and it can be easily, accurately and rapidly determined. Controling the water activity in an appropriate range would help to inhibit the growth and reproduction of microorganisms. This study established a microbial control strategy by determining water activity values of herbs and excipients, intermediate products, and final products of Fengliao Changweikang preparations, and combining with the risk assessment of the production process. This study provided a new idea for the microbial control of non-sterile pharmaceutical products and the development of standards.
The pharmaceutical films are thin sheets formed by various methods such as casting or extrusion, which results in a dispersion of the active pharmaceutical ingredients through the film. They are subject to growing research and have received increasing interests recently due to their convenient administration and improved patient compliance. This review summarizes the marketed products of film dosage form, their quality standards, and storage requirements. Besides, the testing methods of quality inspection items including disintegration time and dissolution are discussed. Finally, brief explanations are provided for the revision of general requirements of pharmaceutical films in the general chapter of the Chinese Pharmacopoeia by comparing with the United States Pharmacopoeia, European Pharmacopoeia, and Japanese Pharmacopoeia.
Orodispersible films are innovative single-layer or multi-layer composite drug-loading films that can be quickly wetted by the patient’s saliva and dissolved in the mouth without the need for drinking water. This review introduces the dosage form characteristics, global development, formulation compositions and process features, research content and general requirements of quality control of orodispersible films. For the quality evaluation of orodispersible films, except for the conventional inspection items of ordinary oral preparations, some special characteristics, such as physical, chemical, and mechanical properties of orodispersible films should also be evaluated based on the dosage form characteristics in order to ensure the safety and effectiveness of the products.
The pharmaceutical films have the characteristics of good patient compliance, convenience for carrying and taking, and accurate dosage. 3D printing technology is an additive manufacturing technology based on computer-aided design models, which generally builds objects by layer-by-layer printing and stacking. It has the advantages of providing complex structures, developing compound preparations and personalized medicines. This review gives an overview of the widely used 3D printing technologies in the preparation of pharmaceutical films, including inkjet printing, fused deposition molding, and semi-solid extrusion. Then, the formulation composition and key process parameters of 3D printing technologies are briefly outlined. It is hoped that this review can provide some references for further researches on the application of 3D printing technology in the field of pharmaceutical films.
In this study, a flow-through cell based apparatus was developed to explore the method of dissolution determination for pharmaceutical films. The results of accuracy tests on sampling and temperature controlling showed that the apparatus performed well on accuracy control under different flow rate conditions of 1, 2 and 5 mL/min. Granisetron hydrochloride orodispersible film, asenapine maleate sublingual film, rasagiline mesylate sublingual film and tadalafil orodispersible film were selected as model drugs to verify the fixed method of film, fluid morphology, and tightness of the dissolution cell, and corresponding improvements were proposed. The results indicated that through dispersing the dissolution media with a filter core, fixing the film with a screen mesh, and enhancing the tightness of dissolution cell, this apparatus could achieve primary functions on dissolution with the potential of application universality for different pharmaceutical films and flow rates.
A physiologically based pharmacokinetic(PBPK) model of asenapine maleate was developed and verified with the oral cavity compartmental absorption and transit(OCCAT) model and advanced compartmental absorption and transit(ACAT) model of GastroPlusTM software combined with the results of pharmacokinetic study of sublingual films in Beagle dogs. The parameter sensitivity analysis was used to quantify the effects of aqueous solubility and in vitro dissolution(Z-factor value) of asenapine maleate on the bioavailability of asenapine maleate sublingual films, and the in vivo dissolution and absorption behaviors were also simulated and predicted. The results indicated that there were delayed absorption and back-diffusion in oral transmucosal absorption of asenapine maleate. The changes in solubility and dissolution did not have significant influences on the oral transmucosal absorption when the solubility was greater than 6.2 mg/mL and the in vitro dissolution in water at 2 min was more than 70%. Based on the mechanistic analysis and prediction of the PBPK model, it was concluded that the solid dispersion technology in the preparation process of asenapine maleate sublingual films could be simplified. The results of pharmacokinetics in Beagle dogs showed that there were no statistical differences in AUC0→∞(P=0.869), cmax(P=0.902) and tmax(P=0.356) values between the sublingual films obtained before and after the process change. As a result, the PBPK modeling and simulation of asenapine sublingual films could be helpful to establish solubility and in vitro dissolution specifications and then be employed to guide drug research and development and support simplification of the preparation process.
The low solubility of flunarizine hydrochloride(1) can lead to the low oral bioavailability. In order to increase the solubility of 1, 1 nanocrystal suspension was prepared by the antisolvent crystallization method in this study. The orodispersible films containing 1 nanocrystals were then prepared by the solvent casting method. The effects of drug loading and relative molecular weight(Mr: 5×104 - 4×105) of HPMC on the critical quality attributes of the orodispersible films were investigated. The results revealed that the redispersibility of the nanocrystalline orodispersible films was not significantly affected when the drug loading was lower than 40%. However, within the test ranges, the larger the Mr of HPMC, the worse the redispersibility of the 1 nanocrystalline orodispersible films. When the drug loading was in the range of 20% - 30%, 1 nanocrystal was evenly distributed in the films containing HPMC E15, HPMC E50, or HPMC E4M as the film forming material. However, when the drug loading was higher than 40%, 1 nanocrystal tended to aggregate in the films. Furthermore, the results showed a good correlation between the erosion and dissolution performance of the films, where the higher the drug loading and Mr of HPMC resulted in the slower the erosion and dissolution rates of the film.